MedPath

Obstructive Sleep Apnoea and Adipose Tissue Dysfunction

Completed
Conditions
Obstructive Sleep Apnoea
Obesity
Hypoxia
Registration Number
NCT02518633
Lead Sponsor
Royal Devon and Exeter NHS Foundation Trust
Brief Summary

Dysfunctional adipose tissue predisposes to cardiovascular disease. Similarly, the risk of cardiovascular disease appears to be increased in subjects with obstructive sleep apnoea. Reduced adipose tissue oxygen availability has been described in obesity and may also be a mechanism in obstructive sleep apnoea. Hypoxia induces inflammation and fibrosis in adipose tissue which are factors contributing to cardiovascular risk. The investigators hypothesize that adipose tissue's oxygen uptake is reduced in subjects with obstructive sleep apnoea by comparing in vivo AT oxygenation and blood flow in tissue of control subjects.

Detailed Description

Assessment includes a adipose tissue biopsy and measurement of oxygenation and blood flow by a Clarke type electrodes and non-invasive Doppler techniques.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
15
Inclusion Criteria
  • men with or without obstructive sleep apnoea
Exclusion Criteria
  • weight loss interventions
  • steroid use
  • active smoking

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
pO2 in adipose tissue by Clarke type electrode4 months

Measurement of pO2 by Clarke type electrode

Secondary Outcome Measures
NameTimeMethod
blood flow in adipose tissue by laser Doppler techniques4 months

assessment of tissue blood flow by laser Doppler techniques

Trial Locations

Locations (2)

NIHR Clinical Research Facility

🇬🇧

Exeter, United Kingdom

Royal Devon and Exeter NHS Foundation Trust

🇬🇧

Exeter, United Kingdom

NIHR Clinical Research Facility
🇬🇧Exeter, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.